Home › Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx
 

Keywords :   


Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx

2016-02-03 03:52:40| drugdiscoveryonline News Articles

DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced today the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays

Tags: development cancer drugs accelerate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Soup sales up as rainy spring affects spending
18.06Potential Tropical Cyclone One Graphics
18.06Atlantic Tropical Weather Outlook
18.06Potential Tropical Cyclone One Public Advisory Number 2A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Eastern North Pacific Tropical Weather Outlook
18.06Apple scraps its Pay Later loan scheme in US
18.06Potential Tropical Cyclone One Public Advisory Number 2
More »